FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | ||
|
|||
Member
|
Biogen has applled for trials in Europe and America for its new Beta-Interferon drug Plegridy. It will require only monthly injections, fewer than Avonex.
I was unable to take Alpha-Interferon for my Polycythemia Vera, so I am not not sanguine about this for MS, but it should be mentioned. Maybe someone else has already mentioned it. |
||
![]() |
![]() |
![]() |
#2 | |||
|
||||
In Remembrance
|
Just a souped of version of Avonex, With the same yucky SX,
at probably twice the cost and says it works better if you shoot yourself evy 2 weeks instead of evy 4 weeks. http://www.medicalnewstoday.com/articles/257962.php
__________________
~Love, Sally . "The best way out is always through". Robert Frost ~If The World Didn't Suck, We Would All Fall Off~ |
|||
![]() |
![]() |
![]() |
#3 | ||
|
|||
Member
|
thanks Sally. You are probably smart to be on LDN. I don't think I could take it with my other dx's. I did bring it up and doctors here thought it was a joke (not a joke, I believe).
Let me say it again, Sally, you are really smart to be on LDN. Yes the pharma will probably charge more for this "improvement". |
||
![]() |
![]() |
Reply |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
Beta interferon has not proven it stops disability progression | Multiple Sclerosis | |||
Biogen tapping into oral MS drug market | Multiple Sclerosis |